与静脉注射相比，灌胃和腹腔注射后的药动学特性发生显著改变。
After ig or IP administration, pharmacokinetic characteristics were significantly changed, compared with iv route.
目的研究8例肝硬化患者静脉滴注奥美拉唑(ome)的药动学特性。
OBJECTIVE To study the pharmacokinetics of omeprazole (ome) in 8 patients with liver cirrhosis.
目的研究盐酸川芎嗪(TMPH)经大鼠鼻腔给药后的脑内药动学特性。
OBJECTIVE To investigate the brain pharmacokinetics of tetramethylpyrazine hydrochloride (TMPH) after intranasal administration in rats.
希美加群是一种新型的口服抗凝剂。现就希美加群的药代学和药动学特性以及围绕其进行的一些临床试验进行简单介绍。
Ximelagatran is a new oral anticoagulant. This article introduces the pharmacodynamic and pharmacokinetic properties of ximelagatran and gives a brief description of some relevant clinical trials.
希美加群是一种新型的口服抗凝剂。现就希美加群的药代学和药动学特性以及围绕其进行的一些临床试验进行简单介绍。
Ximelagatran is a new oral anticoagulant. This article introduces the pharmacodynamic and pharmacokinetic properties of ximelagatran and gives a brief description of some relevant clinical trials.
应用推荐